Session I: Case reports & series| Volume 136, ISSUE 2, P395, February 2015

Download started.


Endometrial adenocarcinoma after risk reducing bilateral salpingo-oophorectomy

      Objectives: Endometrial adenocarcinoma after risk-reducing salpingo-oophorectomy (RRSO) is rare. There have been reports of an increased incidence of high-risk uterine cancer in BRCA positive women, both among those taking tamoxifen and those who were not. However, low risk uterine cancer in BRCA positive women after RRSO has not been observed.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Gynecologic Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect